Does deep brain stimulation for Parkinson’s increase the risk of dementia?

News

Author: Simge Eva DoganPublished: 9 July 2020

Prep: Cook: Serves:

cropped view of senior man playing with puzzles

Researchers in France have found that deep brain stimulation for Parkinson’s may not increase the risk of developing dementia.

As part of the study – published by the American Academy of Neurology – researchers identified 175 people with Parkinson’s and an average age of 56, who had deep brain stimulation. The individuals were assessed over a period of 10 years to determine if they had developed dementia.

After one year, four individuals had developed dementia. After five years, 142 people from the original group were available for testing, 12 of whom had dementia. After 10 years, 104 people were available for testing, 31 of whom had dementia.

Dr Elena Moro, author of the study, said: “These results are very encouraging for people with Parkinson’s and their families that they can take advantage of the benefits of deep brain stimulation without worrying about it increasing the likelihood of developing dementia.”

To read more on this topic click here.

For more information on the latest Parkinson’s research please visit the EPDA website.

Could a magnetically powered implant treat Parkinson’s tremors?

Last Month

Next Month

Go Back

Share this story

Comments

Interviews

Meet Andy Butler, the man behind the Parkinson’s People Facebook group

One of Facebook’s largest independent Parkinson’s groups

New research reveals a way of monitoring the activity of gene mutations that cause Parkinson’s

Scientists develop a new way to measure PD gene mutations

Ask the expert: How to spot fake Parkinson’s medicines online

Mike Isles shares his top tips on how to stay safe

New insights on immune cell process and Parkinson’s disease

Insoluble clumps of the protein alpha-synuclein, which can cause damage to brain cells, have been previously linked to Parkinson’s. Now, scientists in Germany, France and the US have uncovered new details on how brain cells respond to these clusters. The researchers discovered that the brain’s immune cells may be able to join together to break down the protein clumps. According to a press release, this was previously unknown. They also found that these neighbouring cells share mitochondria – structures that generate energy for chemical reactions – to help one another. In certain mutations associated with Parkinson’s, this process may be impaired. The researchers hope this insight could inform the development of new therapies. “We have opened the door to a field that will certainly engage researchers for many years to come,” said Professor Dr Michael Heneka, director of the Department of Neurodegenerative Diseases and Geriatric Psychiatry at the University Hospital…

Could analysing skin oil help diagnose Parkinson’s disease?

Parkinson’s disease patients tend to have high levels of oil, known as sebum, on their skin’s surface. Now, a study has suggested that analysing this substance may help when diagnosing the condition. The study revealed that sebum contains significant amounts of genetic material, specifically the molecule ribonucleic acid (RNA). Analysis of RNA contained in sebum – that is, skin surface lipids RNA, or SSL-RNA – could offer insights into a person’s health. Researchers in Japan examined SSL-RNA in men and women with and without Parkinson’s. The results suggested that the SSL-RNA profiles of those with Parkinson’s had “different characteristics” than those without. The researchers then tested whether examining these profiles with machine learning could reveal those who had Parkinson’s – and who didn’t. The team’s algorithm indicated a “relatively robust discriminatory ability,” supporting the further use of SSL-RNA as part of a future “non-invasive” method for diagnosis.

‘Sonic hedgehog’ protein could impact Parkinson’s disease dyskinesia

Dyskinesia is often caused by extended use of the common Parkinson’s medication levodopa – and can be debilitating for those with the condition. Now, researchers in the US may have found a way to suppress these involuntary movements through a protein called ‘sonic hedgehog’. To conduct their study, the team administered levodopa and sonic hedgehog agonists to rodent and non-human primate models of the condition. The results revealed that dopamine neurons use the protein to communicate with other neurons thought to play a role in levodopa-induced dyskinesia. Increased signalling of sonic hedgehog pathways was found to reduce this dyskinesia – providing “novel insight” into its formation and a “potential therapeutic solution”. “What we find,” wrote corresponding study author Professor Andreas Kottmann, “is that in several animal models, by replacing … dopamine together with agonists that mimic the effects of sonic hedgehog, these dyskinesias can be very much suppressed.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Phone
This field is for validation purposes and should be left unchanged.

Does deep brain stimulation for Parkinson’s increase the risk of dementia?

News

Author: Simge Eva DoganPublished: 9 July 2020

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Interviews

Meet Andy Butler, the man behind the Parkinson’s People Facebook group

Advances

New research reveals a way of monitoring the activity of gene mutations that cause Parkinson’s

Special reports

Ask the expert: How to spot fake Parkinson’s medicines online

New insights on immune cell process and Parkinson’s disease

Could analysing skin oil help diagnose Parkinson’s disease?

‘Sonic hedgehog’ protein could impact Parkinson’s disease dyskinesia

{title}

Subscribe

Does deep brain stimulation for Parkinson’s increase the risk of dementia?

News

Author: Simge Eva DoganPublished: 9 July 2020

Last Month

Next Month

Share this story

Comments

Related articles

Interviews

Meet Andy Butler, the man behind the Parkinson’s People Facebook group

Advances

New research reveals a way of monitoring the activity of gene mutations that cause Parkinson’s

Special reports

Ask the expert: How to spot fake Parkinson’s medicines online

New insights on immune cell process and Parkinson’s disease

Could analysing skin oil help diagnose Parkinson’s disease?

‘Sonic hedgehog’ protein could impact Parkinson’s disease dyskinesia

{title}

Subscribe

Sign in